NSC |
Compound |
Enrichment |
Correlation |
NSC 726217 |
Combretastatin A4-analogue |
0.0401206532535671 |
0.38526838 |
NSC 731701 |
1[(4-n-butyloxyCarbonyl)piperazine-1-yl]diazene-1-ium-1,2-di olate |
0.0401206532535671 |
-0.05771931 |
NSC 732205 |
Null |
0.0401206532535671 |
0.45567603 |
NSC 735472 |
(2E,8S,9Z)-2,9,16-heptadecatrien-4,6-diyn-1,8-diol |
0.0401206532535671 |
0.34173173 |
NSC 741425 |
3,7-di(trifluoromethyl)-2-naftoylquioxaline 1,4-dioxide |
0.0401206532535671 |
0.28930261 |
NSC 744023 |
(11aS)-8-(3-{4-[(E)-3-(2-hydroxyphenyl)-3-oxo-1-propenyl]-2-methoxyphenoxy}propoxy)-7-methoxy-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-5-one |
0.0401206532535671 |
0.25595634 |
NSC 744688 |
Null |
0.0401206532535671 |
0.27515643 |
NSC 753427 |
2.5-anhydro-1-(3,4,5-trimethoxyphenyl)-1-[3-hydroxy-4-methoxyphenyl]-1-desoxy-3.4:6.7-di-O-isopropylidene-L-glucohept-1-enitol |
0.0401206532535671 |
0.25474184 |
NSC 753456 |
2-4-[5-(3,5-dimethoxyphenyl)-1H-1-imidazolyl]phenyl-5,6,7-trimethoxy-1,3-benzothiazole |
0.0401206532535671 |
0.28794723 |
NSC 755442 |
Null |
0.0401206532535671 |
0.10910193 |